Results 181 to 190 of about 51,867 (216)

Screening cognitive and academic problems in Duchenne Muscular Dystrophy: Validity and reliability of the Kempenhaeghe Learning Questionnaire. [PDF]

J Neuromuscul Dis
Weerkamp PM, Miranda R, Chieffo D, Geagan C, Niks EH, Vermeulen RJ, Desguerre I, Straub V, Wuergler Slipsager A, Kolesnik A, Vroom E, Skuse D, Muntoni F, Mercuri E, Klinkenberg S, Hendriksen JG, BIND Consortium Clinical Working Group.   +16 more
europepmc   +1 more source

Case Report: The effect of early initiation of eteplirsen treatment on the cardiac and motor disease course in an individual with Duchenne muscular dystrophy. [PDF]

Front Pediatr
Masalha Y, Zehavi Y, Musallam B, Khamaysi M, Abu Omer M, Fink DL, Spiegel R.   +6 more
europepmc   +1 more source

Data for Coevolution and temporal dynamics of species interactions shape species coexistence (Version v1)

Bartomeus, Ignasi, Domínguez-García, Virginia, Duchenne, François, Molina, Francisco P.   +3 more
core   +1 more source

Correction: Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment. [PDF]

Cell Death Dis
Fernández-Simón E, Tejedera-Villafranca A, Fernández-Garabay X, Clark J, Katsikis P, Mehra P, Galloway A, Monceau A, Villalobos E, Cox D, Ramón-Azcón J, Fernández-Costa JM, Díaz-Manera J.   +12 more
europepmc   +1 more source

Fat Embolism Syndrome Following Elective Orthopedic Surgery in a Patient With Duchenne Muscular Dystrophy. [PDF]

Cureus
Hassan K, Desai R, Shahin E, Shapiro P, Burshtain O, Dragone D.   +5 more
europepmc   +1 more source

Duchenne muscular dystrophy coexisting with Down syndrome or Turner syndrome: Two case reports. [PDF]

World J Clin Pediatr
Pongsakornkullachart P, Chanvanichtrakool M, Dhachpramuk D, Pho-Iam T, Yongwattana N, Kulsirichawaroj P, Tanboon J, Sanmaneechai O.   +7 more
europepmc   +1 more source

Artificial Intelligence in Neuromuscular Diseases: Opportunities for a Data-Scarce Field. [PDF]

Neurol Ther
Ma S, Luo S, Zhong H.
europepmc   +1 more source

Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies. [PDF]

Mol Ther Nucleic Acids
Vermeer C, Venema RR, Birnie E, Bolling MC, Knoers N, Bremer J, van den Akker PC.   +6 more
europepmc   +1 more source